Captopril

CAS No. 62571-86-2

Captopril ( SA 333; SQ 14,225 )

Catalog No. M15369 CAS No. 62571-86-2

Captopril is a potent, competitive inhibitor of angiotensin-converting enzyme (ACE).

Purity : >98%(HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
50MG 36 In Stock
100MG 43 In Stock
200MG 53 In Stock
500MG 73 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Captopril
  • Note
    Research use only, not for human use.
  • Brief Description
    Captopril is a potent, competitive inhibitor of angiotensin-converting enzyme (ACE).
  • Description
    Captopril is a potent, competitive inhibitor of angiotensin-converting enzyme (ACE).
  • Synonyms
    SA 333; SQ 14,225
  • Pathway
    Endocrinology/Hormones
  • Target
    RAAS
  • Recptor
    ACE
  • Research Area
    Cardiovascular Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    62571-86-2
  • Formula Weight
    217.29
  • Molecular Formula
    C9H15NO3S
  • Purity
    >98%(HPLC)
  • Solubility
    Ethanol: 43 mg/mL (197.89 mM); Water: 2 mg/mL (9.2 mM); DMSO: 43 mg/mL (197.89 mM)
  • SMILES
    O=C([C@H]1N(C([C@H](C)CS)=O)CCC1)O
  • Chemical Name
    (2S)-1-[(2S)-2-methyl-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Andujar-Sanchez M, et al. FEBS Lett. 2007 Jul 24;581(18):3449-54.
molnova catalog
related products
  • Angiotensin II human

    Angiotensin II human is converted by Angiotensin I through removal of two C-terminal residues by the enzyme angiotensin-converting enzyme (ACE).

  • DX600 TFA

    DX600 TFA is a specific inhibitor of ACE2 and does not cross-react with ACE.

  • N-Acetyl-Ser-Asp-Lys...

    Acetyl Ser-Asp-Lys-Pro is formed in bone marrow cells by enzymatic processing of thymosin β4. It inhibits the entry of pluripotent hemopoietic stem cells into S-phase of the cell cycle and protects against Ara-C lethality in mice.N-Acetyl-Ser-Asp-Lys-Pro (AcSDKP) is a specific substrate for the N-terminal site of ACE and increases 5-fold during ACE inhibitor therapy.??AcSDKP inhibited the proliferation of isolated cardiac fibroblasts (P<0.05) but significantly stimulated the proliferation of vascular smooth muscle cells.?